| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, Georgia 30329-4251
Body weight and height have both been associated consistently with postmenopausal breast cancer but less consistently with prostate cancer. The present study examined the relationship between body mass index (BMI), height, and death from prostate cancer in two large American Cancer Society cohorts. Men in the study were selected from the male participants in Cancer Prevention Study I (CPS-I; enrolled in 1959 and followed through 1972) and Cancer Prevention Study II (CPS-II; enrolled in 1982 and followed through 1996). After exclusions, 1,590 prostate cancer deaths remained among 381,638 men in CPS-I and 3,622 deaths among 434,630 men in CPS-II. Cox proportional hazards modeling was used to compute rate ratios (RR) and to adjust for confounders. Prostate cancer mortality rates were significantly higher among obese (BMI, 
30) than nonobese (BMI, <25) men in both cohorts [adjusted RR, 1.27; 95% confidence interval (CI), 1.04–1.56 in CPS-I; RR, 1.21; 95% CI, 1.07–1.37 in CPS-II]. Prostate cancer mortality rates in the CPS-I cohort were lowest for the shortest men (RR, 0.80; 95% CI, 0.63–1.03 for men <65 inches versus 65–66 inches) and highest for the tallest men (RR, 1.39; 95% CI, 1.11–1.74 for men 73 inches tall versus 65–66 inches). Rates remained constant among men 65–72 inches tall. No association between height and prostate cancer mortality was observed in the CPS-II cohort (RR, 1.03; 95% CI, 0.82–1.29 for men 75 versus 65–66 inches). These results support the hypothesis that obesity increases risk of prostate cancer mortality. Decreased survival among obese men may be a likely explanation for this association.
This article has been cited by other articles:
|
|
 |
|
  L. Zuccolo, R. Harris, D. Gunnell, S. Oliver, J. A. Lane, M. Davis, J. Donovan, D. Neal, F. Hamdy, R. Beynon, et al. Height and Prostate Cancer Risk: A Large Nested Case-Control Study (ProtecT) and Meta-analysis Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2325 - 2336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jayachandran and S. J. Freedland Prevention of Prostate Cancer: What We Know and Where We Are Going American Journal of Men's Health, June 1, 2008; 2(2): 178 - 189. [Abstract] [PDF]
|
|
|
|
 |
|
 L. L. Banez, R. J. Hamilton, A. W. Partin, R. T. Vollmer, L. Sun, C. Rodriguez, Y. Wang, M. K. Terris, W. J. Aronson, J. C. Presti Jr, et al. Obesity-Related Plasma Hemodilution and PSA Concentration Among Men With Prostate Cancer JAMA, November 21, 2007; 298(19): 2275 - 2280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W Hsing, L. C Sakoda, and S. C Chua Jr Obesity, metabolic syndrome, and prostate cancer Am. J. Clinical Nutrition, September 1, 2007; 86(3): 843S - 857S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Littman, E. White, and A. R. Kristal Anthropometrics and Prostate Cancer Risk Am. J. Epidemiol., June 1, 2007; 165(11): 1271 - 1279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Freedland and E. A. Platz Obesity and Prostate Cancer: Making Sense out of Apparently Conflicting Data Epidemiol. Rev., May 3, 2007; (2007) mxm006v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Michalakis, C. J. Williams, N. Mitsiades, J. Blakeman, S. Balafouta-Tselenis, A. Giannopoulos, and C. S. Mantzoros Serum Adiponectin Concentrations and Tissue Expression of Adiponectin Receptors Are Reduced in Patients with Prostate Cancer: A Case Control Study Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 308 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Werny, T. Thompson, M. Saraiya, D. Freedman, B. J. Kottiri, R. R. German, and M. Wener Obesity Is Negatively Associated with Prostate-Specific Antigen in U.S. Men, 2001-2004 Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 70 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rodriguez, S. J. Freedland, A. Deka, E. J. Jacobs, M. L. McCullough, A. V. Patel, M. J. Thun, and E. E. Calle Body Mass Index, Weight Change, and Risk of Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 63 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Smith Obesity and Sex Steroids during Gonadotropin-Releasing Hormone Agonist Treatment for Prostate Cancer Clin. Cancer Res., January 1, 2007; 13(1): 241 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Gong, M. L. Neuhouser, P. J. Goodman, D. Albanes, C. Chi, A. W. Hsing, S. M. Lippman, E. A. Platz, M. N. Pollak, I. M. Thompson, et al. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1977 - 1983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Lockett, M.C. Hall, P. E. Clark, S.-C. Chuang, B. Robinson, H.-Y. Lin, L.J. Su, and J. J. Hu DNA damage levels in prostate cancer cases and controls Carcinogenesis, June 1, 2006; 27(6): 1187 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Batty, M. J. Shipley, C. Langenberg, M. G. Marmot, and G. Davey Smith Adult height in relation to mortality from 14 cancer sites in men in London (UK): evidence from the original Whitehall study Ann. Onc., January 1, 2006; 17(1): 157 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. D. Yumuk and P. F. Yumuk What Links Obesity to Cancer? Indoor and Built Environment, December 1, 2005; 14(6): 527 - 532. [Abstract] [PDF]
|
|
|
|
|
|
S. J. Freedland, W. J. Aronson, B. Trock, P. Cohen, C. J. Kane, C. L. Amling, J. C. Presti Jr., M. K. Terris, and for the Shared Equal Access Regional Cancer Hospit Racial Differences in Prognostic Value of Adult Height for Biochemical Progression Following Radical Prostatectomy Clin. Cancer Res., November 1, 2005; 11(21): 7735 - 7742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Freedland Obesity and Prostate Cancer: A Growing Problem Clin. Cancer Res., October 1, 2005; 11(19): 6763 - 6766. [Full Text] [PDF]
|
|
|
|
|
|
W. R. Robinson, J. Stevens, M. D. Gammon, and E. M. John Obesity before Age 30 Years and Risk of Advanced Prostate Cancer Am. J. Epidemiol., June 15, 2005; 161(12): 1107 - 1114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Freedland, W. B. Isaacs, L. A. Mangold, S. K. Yiu, K. A. Grubb, A. W. Partin, J. I. Epstein, P. C. Walsh, and E. A. Platz Stronger Association between Obesity and Biochemical Progression after Radical Prostatectomy among Men Treated in the Last 10 Years Clin. Cancer Res., April 15, 2005; 11(8): 2883 - 2888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jemal, E. Ward, X. Wu, H. J. Martin, C. C. McLaughlin, and M. J. Thun Geographic Patterns of Prostate Cancer Mortality and Variations in Access to Medical Care in the United States Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 590 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Amling, R. H. Riffenburgh, L. Sun, J. W. Moul, R. S. Lance, L. Kusuda, W. J. Sexton, D. W. Soderdahl, T. F. Donahue, J. P. Foley, et al. Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical Prostatectomy J. Clin. Oncol., February 1, 2004; 22(3): 439 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Freedland, W. J. Aronson, C. J. Kane, J. C. Presti Jr, C. L. Amling, D. Elashoff, and M. K. Terris Impact of Obesity on Biochemical Control After Radical Prostatectomy for Clinically Localized Prostate Cancer: A Report by the Shared Equal Access Regional Cancer Hospital Database Study Group J. Clin. Oncol., February 1, 2004; 22(3): 446 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Y. Pan, K. C. Johnson, A.-M. Ugnat, S. W. Wen, and Y. Mao Association of Obesity and Cancer Risk in Canada Am. J. Epidemiol., February 1, 2004; 159(3): 259 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Boyd Insulin and Cancer Integr Cancer Ther, December 1, 2003; 2(4): 315 - 329. [Abstract] [PDF]
|
|
|
|
|
|
R. J. MacInnis, D. R. English, D. M. Gertig, J. L. Hopper, and G. G. Giles Body Size and Composition and Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1417 - 1421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W.-M. Boileau, Z. Liao, S. Kim, S. Lemeshow, J. W. Erdman Jr., and S. K. Clinton Prostate Carcinogenesis in N-methyl-N-nitrosourea (NMU)-Testosterone-Treated Rats Fed Tomato Powder, Lycopene, or Energy-Restricted Diets J Natl Cancer Inst, November 5, 2003; 95(21): 1578 - 1586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Onuma, J. D. Bub, T. L. Rummel, and Y. Iwamoto Prostate Cancer Cell-Adipocyte Interaction: LEPTIN MEDIATES ANDROGEN-INDEPENDENT PROSTATE CANCER CELL PROLIFERATION THROUGH c-Jun NH2-TERMINAL KINASE J. Biol. Chem., October 24, 2003; 278(43): 42660 - 42667. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Calle, C. Rodriguez, K. Walker-Thurmond, and M. J. Thun Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults N. Engl. J. Med., April 24, 2003; 348(17): 1625 - 1638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chen, B. A. Miller, E. Giovannucci, and R. B. Hayes Height and the Survival of Prostate Cancer Patients Cancer Epidemiol. Biomarkers Prev., March 1, 2003; 12(3): 215 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chang, X. Wu, H. Yu, and M. R. Spitz Plasma Concentrations of Insulin-like Growth Factors among Healthy Adult Men and Postmenopausal Women: Associations with Body Composition, Lifestyle, and Reproductive Factors Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 758 - 766. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
